These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8135491

  • 1. Immune defects in patients with head and neck cancer.
    Wustrow TP, Issing WJ.
    Anticancer Res; 1993; 13(6B):2507-19. PubMed ID: 8135491
    [Abstract] [Full Text] [Related]

  • 2. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL, McLaren JR, Skeen MJ.
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [Abstract] [Full Text] [Related]

  • 3. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
    Rabin BS, Johnson J, Claassen D.
    Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
    [Abstract] [Full Text] [Related]

  • 4. Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.
    Dawson DE, Everts EC, Vetto RM, Burger DR.
    Ann Otol Rhinol Laryngol; 1985 May; 94(4 Pt 1):342-5. PubMed ID: 3875306
    [Abstract] [Full Text] [Related]

  • 5. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S, Hirabayashi H, Schwartz DR, Toso JF, Johnson JT, Herberman RB, Whiteside TL.
    Cancer Res; 1993 Mar 15; 53(6):1461-8. PubMed ID: 8443824
    [Abstract] [Full Text] [Related]

  • 6. Immunology of head and neck cancers.
    Newbill ET, Johns ME.
    Crit Rev Clin Lab Sci; 1983 Mar 15; 19(1):1-25. PubMed ID: 6201320
    [Abstract] [Full Text] [Related]

  • 7. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma.
    Kerrebijn JD, Simons PJ, Balm AJ, Tas M, Knegt PP, de Vries N, Tan IB, Drexhage HA.
    Head Neck; 1996 Mar 15; 18(4):335-42. PubMed ID: 8780944
    [Abstract] [Full Text] [Related]

  • 8. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM, van der Laak JA, de Vries IJ, van Krieken JH, de Wilde PC, Balvers MG, Adema GJ, De Mulder PH.
    Clin Cancer Res; 2005 Mar 01; 11(5):1899-909. PubMed ID: 15756016
    [Abstract] [Full Text] [Related]

  • 9. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2.
    Meneses A, Verastegui E, Barrera JL, de la Garza J, Hadden JW.
    Int Immunopharmacol; 2003 Aug 01; 3(8):1083-91. PubMed ID: 12860165
    [Abstract] [Full Text] [Related]

  • 10. Transference of cell mediated immunity in patients with head and neck cancer.
    Vetto RM, Burger DR.
    Laryngoscope; 1978 Jan 01; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
    [Abstract] [Full Text] [Related]

  • 11. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
    Whiteside TL, Letessier E, Hirabayashi H, Vitolo D, Bryant J, Barnes L, Snyderman C, Johnson JT, Myers E, Herberman RB.
    Cancer Res; 1993 Dec 01; 53(23):5654-62. PubMed ID: 8242620
    [Abstract] [Full Text] [Related]

  • 12. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR, Kukwa A, Croft CB, Borowiecki B, Silver C, Emeson EE.
    Laryngoscope; 1979 Apr 01; 89(4):538-49. PubMed ID: 311881
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
    Stefano S, Kerman R, Abbate J.
    AJR Am J Roentgenol; 1976 Apr 01; 126(4):880-6. PubMed ID: 179361
    [Abstract] [Full Text] [Related]

  • 15. Cellular immune profile and T-lymphocyte blocking factors in cancer of the head and neck and their prognostic significance.
    Sinha R, Gupta SC, Naithani YP.
    Indian J Cancer; 1985 Mar 01; 22(1):8-16. PubMed ID: 3879757
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck.
    Okada K, Yasumura S, Muller-Fleckenstein I, Fleckenstein B, Talib S, Koldovsky U, Whiteside TL.
    Cell Immunol; 1997 Apr 10; 177(1):35-48. PubMed ID: 9140094
    [Abstract] [Full Text] [Related]

  • 18. Histologic findings in patients with head and neck squamous cell carcinoma receiving perilymphatic natural cytokine mixture (IRX-2) prior to surgery.
    Meneses A, Verastegui E, Barrera JL, Zinser J, de la Garza J, Hadden JW.
    Arch Pathol Lab Med; 1998 May 10; 122(5):447-54. PubMed ID: 9593347
    [Abstract] [Full Text] [Related]

  • 19. [Antigen-specific antibody formation in determining the immune reaction in patients with head and neck cancers].
    Wustrow TP.
    Laryngorhinootologie; 1989 Mar 10; 68(3):169-80. PubMed ID: 2469429
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.